- 3.3Impact Factor
- 5.9CiteScore
- 21 daysTime to First Decision
Nuclear Medicine and Molecular Imaging Technology
This special issue belongs to the section “Medical Imaging and Theranostics“.
Special Issue Information
Dear Colleagues,
Nuclear medicine and molecular imaging uses radioactive substances called radiopharmaceuticals to evaluate the function of organs and/or tissues, or to examine for the presence of disease and characterize disease. These types of technologies often have an advantage over other types of diagnostic imaging in that they provide information that is unattainable with other imaging technologies or that would require more invasive procedures, such as biopsy or surgery. In contrast to the latter procedures, molecular imaging elegantly circumvents the risk of sampling error as the whole body is imaged. Characterization of disease by molecular imaging may serve as companion diagnostic for selecting patients eligible for specific therapies and, together with targeted radionuclide therapy, form a theranostic pair.
This Topical Collection aims to collect original works related to nuclear medicine and molecular imaging research.
Prof. Dr. Andreas Kjaer
Collection Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Positron Emission Tomography (PET)
- Magnetic Resonance Imaging (MRI)
- PET/MRI
- Single-photon Emission Computed Tomography (SPECT)
- optical imaging
- radiopharmaceuticals
- molecular imaging probes
- targeted radionuclide therapy
- theranostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

